Cutting-edge cancer treatment isn't known by most Americans

Updated on: May 20,2025 0

Cutting-edge cancer treatment isn't known by most Americans

Updated on:May 20,2025 0

How metabolic chatter between cells undermines anti-tumor immunity

Updated on: August 14,2025 0

How metabolic chatter between cells undermines anti-tumor immunity

Updated on:August 14,2025 0

Blood-based screening has acceptable accuracy for colorectal cancer detection

Updated on: July 12,2025 0

Blood-based screening has acceptable accuracy for colorectal cancer detection

Updated on:July 12,2025 0

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Updated on: May 20,2025 0

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Updated on:May 20,2025 0

Drug therapy lenacapavir may effectively control HIV in Uganda

Updated on: March 29,2025 0

Drug therapy lenacapavir may effectively control HIV in Uganda

Updated on:March 29,2025 0

NIH research funding drops $1B under Trump administration

Updated on: March 29,2025 0

NIH research funding drops $1B under Trump administration

Updated on:March 29,2025 0

Could this molecule be 'checkmate' for coronaviruses like SARS-CoV-2?

Updated on: May 16,2025 0

Could this molecule be 'checkmate' for coronaviruses like SARS-CoV-2?

Updated on:May 16,2025 0

New immune targets identified in glioblastoma: CD44 and TNFSF14 may help guide future therapies

Updated on: July 14,2025 0

New immune targets identified in glioblastoma: CD44 and TNFSF14 may help guide future therapies

Updated on:July 14,2025 0

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Updated on: October 06,2025 0

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Updated on:October 06,2025 0

Weekly Update of Drug News-22/10/2025

On Oct 6 2025, AbbVie announced positive topline results from its Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) for upper limb essential tremor compared to placebo.

Updated on: October 22,2025 0

Weekly Update of Drug News-22/10/2025

On Oct 6 2025, AbbVie announced positive topline results from its Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) for upper limb essential tremor compared to placebo.

Updated on:October 22,2025 0